PubRank

H Tamamura

Author PubWeight™ 23.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 1997 2.09
2 An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 2000 1.42
3 Treatment of renovascular hypertension using stent implantation in an elderly patient with NIDDM. Intern Med 2000 1.40
4 T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J Virol 1999 1.22
5 Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells. J Virol 1994 1.06
6 Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J Virol 1999 1.04
7 A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II). Biochem Biophys Res Commun 1992 1.04
8 A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma. Biochem Biophys Res Commun 2004 1.01
9 A single retroviral gag precursor signal peptide recognized by FBL-3 tumor-specific cytotoxic T lymphocytes. J Virol 1995 0.97
10 Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134. AIDS Res Hum Retroviruses 2001 0.87
11 Stereoselective synthesis of CF(2)-substituted phosphothreonine mimetics and their incorporation into peptides using newly developed deprotection procedures. J Org Chem 2000 0.85
12 Orbital fractures: surface coil MR imaging. Radiology 1991 0.83
13 The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule. Biochem Biophys Res Commun 1995 0.80
14 Improvement of lentiviral vector-mediated gene transduction by genetic engineering of the structural protein Pr55 Gag. Gene Ther 2010 0.80
15 Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1. J Infect Chemother 2001 0.80
16 Peptide-lead CXCR4 antagonists with high anti-HIV activity. Curr Opin Investig Drugs 2001 0.79
17 Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4. AIDS Res Hum Retroviruses 1999 0.79
18 Overlapping epitopes of friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T-lymphocyte clones. Immunol Lett 1998 0.78
19 Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Pancreastatin inhibits central vagal nerve stimulation. Gastroenterology 1990 0.78
20 New HIV-drug inhibits in vitro bladder cancer migration and invasion. Eur Urol 2005 0.78
21 Isolation and characterization of a tumor-derived human pancreastatin-related protein. Biochem Biophys Res Commun 1989 0.78
22 Bioactivity of synthetic human pancreastatin on exocrine pancreas. Biochem Biophys Res Commun 1988 0.77
23 Induction of cross-reactivity in an endogenous viral peptide non-reactive to FBL-3 tumor-specific helper T-cell clones. Microbiol Immunol 1998 0.77
24 Plasma pancreastatin-like immunoreactivity in various diseases. J Clin Endocrinol Metab 1989 0.76
25 [A case of retroperitoneal inflammation: diagnostic usefulness of MRI]. Rinsho Hoshasen 1987 0.75
26 [Bronchial arterial hemodynamics after thoracic irradiation therapy in lung cancer patients]. Nihon Kyobu Shikkan Gakkai Zasshi 1994 0.75
27 [A case of radiation pneumonitis caused by treatment of lung cancer which revealed marked hypervasculality on bronchial arteriography]. Nihon Kyobu Shikkan Gakkai Zasshi 1993 0.75
28 Efficient induction of peptide-specific cytotoxic T lymphocytes by LPS-activated spleen cells. Microbiol Immunol 2000 0.75
29 Comparative effects of mammalian pancreastatins on the pancreatic exocrine secretion. Jpn J Physiol 1989 0.75
30 A new practical strategy for the synthesis of long-chain phosphopeptide. Chem Pharm Bull (Tokyo) 2000 0.75
31 Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II). Biol Pharm Bull 1994 0.75
32 Bioactivity of human pancreastatin and its localization in pancreas. Biochem Biophys Res Commun 1989 0.75
33 [Development of and experience with 3-lumen double-balloon catheters for use in superselective angiography]. Rinsho Hoshasen 1990 0.75
34 Bioactivity of synthetic C-terminal fragment of rat pancreastatin on endocrine pancreas. Biochem Biophys Res Commun 1989 0.75
35 Intraocular lesions in patients with systemic disease: findings on MR imaging. AJR Am J Roentgenol 1990 0.75
36 Single photon emission CT images in a case of intraventricular neurocytoma. Ann Nucl Med 1998 0.75
37 [Efficiency of segmental SMANCS/Lip-TAE for hepatocellular carcinoma--comparative studies in the efficacy of segmental SMANCS/Lip-TAI]. Gan To Kagaku Ryoho 1997 0.75
38 Calcified mediastinal metastases from ovarian cancer imaged with Tc-99m MDP SPECT. Clin Nucl Med 1998 0.75
39 [Percutaneous removal of foreign bodies from the cardiovascular system: two experienced cases in addition to a review of 35 cases reported over the past 9 years in Japan]. Kyobu Geka 1993 0.75
40 High plasma pancreastatinlike immunoreactivity in a patient with malignant insulinoma. Gastroenterology 1989 0.75
41 Lymphocytes and promonocytes attach to the synthetic [Tyr5,12, Lys7]- polyphemusin II peptide. Biochem Biophys Res Commun 1994 0.75
42 Intraocular lesions in patients with systemic disease: findings on MR imaging. AJNR Am J Neuroradiol 1990 0.75
43 Decline of anti-DP107 antibody associated with clinical progression. AIDS 1998 0.75
44 [New method for preparing proximal anastomotic system]. Kyobu Geka 2006 0.75
45 The importance of the C-terminal amide structure of rat pancreastatin to inhibit pancreatic exocrine secretion. FEBS Lett 1990 0.75
46 [Radiation therapy for advanced gastric cancer]. Gan To Kagaku Ryoho 1997 0.75
47 Rat pancreastatin inhibits both pancreatic exocrine and endocrine secretions in rats. Regul Pept 1990 0.75